Literature DB >> 23575753

Biventricular amputation for biventricular pulsatile assist device implantation in patients with severe ventricular septal perforation.

Marcel Vollroth1, Joerg Seeburger, Friedrich W Mohr, Michael A Borger.   

Abstract

Complete ischaemic destruction of the cardiac apex as well as the majority of the ventricular septum is usually a lethal condition with no alternatives except mechanical circulation support and highly urgent heart transplantation. Depending on the mass of the necrotic and destructed myocardium, implantation of a ventricular assist device can be challenging due to insufficient tissue quality. We describe here a new approach to pulsatile Thoratec (Thoratec Corporation, Pleasanton, CA, USA) extracorporeal biventricular assist device implantation.

Entities:  

Year:  2013        PMID: 23575753      PMCID: PMC3686404          DOI: 10.1093/icvts/ivt152

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  4 in total

1.  Surgical repair of ruptured interventricular septum following acute myocardial infarction.

Authors:  D A COOLEY; B A BELMONTE; L B ZEIS; S SCHNUR
Journal:  Surgery       Date:  1957-06       Impact factor: 3.982

2.  Combined surgical left ventricular reconstruction and left ventricular assist device implantation for destination therapy in end-stage heart failure.

Authors:  Jens Garbade; Hartmuth B Bittner; Markus J Barten; Ardawan Rastan; Sven Lehmann; Friedrich-Wilhelm Mohr; Michael Andrew Borger
Journal:  Circ Heart Fail       Date:  2011-07       Impact factor: 8.790

3.  Short-term and long-term outcomes of postinfarction ventricular septal perforation.

Authors:  Kenichiro Noguchi; Atsushi Yamaguchi; Kazuhiro Naito; Kouichi Yuri; Hideo Adachi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-03-28

4.  Cardiogenic shock in patient with posterior postinfarction septal rupture--successful treatment with extracorporeal membrane oxygenation (ECMO) as a ventricular assist device.

Authors:  Vilém Rohn; Miroslav Spacek; Jan Belohlavek; Jan Tosovsky
Journal:  J Card Surg       Date:  2008-09-05       Impact factor: 1.620

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.